Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
PhD ceremony: Mr. A.R.M. van der Bilt, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
Promotor(s): prof. E.G.E. de Vries, prof. A.G.J. van der Zee, prof. S. de Jong
Faculty: Medical Sciences
Standard therapy for ovarian cancer, consisting of platinum-based chemotherapy and surgical debulking, has been unchanged since its introduction over a decade ago. Other chemotherapeutic regimens did not improve the poor prognosis of advanced ovarian cancer patients. Alternative therapeutic strategies are therefore being pursued, by applying molecular targeted drugs. These drugs interfere with key biological processes relevant to ovarian cancer biology, amongst which are the potential of these cancers to evade programmed cell death (apoptosis) and to create a vascular supply (angiogenesis). In this thesis the effects of proapoptotic and anti-angiogenic targeted drugs was investigated in preclinical ovarian cancer models.
| Last modified: | 13 March 2020 01.01 a.m. |
More news
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
28 February 2025
Vici grants for two UG/UMCG scientists
The Dutch Research Council (NWO) has awarded Vici grants, worth up to €1.5 million each, to Merel Keijzer and Charalampos Tsoumpas This will enable the researchers to develop an innovative line of research and set up their own research group for...
-
11 February 2025
Space for your disability
When it comes to collaborations between researchers from different faculties, the UG is at the top of its game. A prime example is the Disabled City project that researches how the mobility of people with a physical disability can be explored...